Internal medicine and external therapy for the management of cerebral palsy children in siddha system

Preclinical and clinical Evaluation of Siravatham(Cerebral palsy)with with Siddha Therapeutic Management in children.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013322

Enrollment

Registered

2018-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- stiffness, abnormal gait

Interventions

Intervention1: kurunthotti kudineer and vasavu ennai , Kollu podithimirthal (External): kurunthotti kudineer (internal ) Dosage: 2 to 4years - 30 ml(bds) 5 to 7 years - 40 ml twice a day vasavu enna

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children of age group under 2- 7 year 2 Clinically diagnosed as a cerebral palsy (spastic) 3 Not attained head control 4 Drooling of saliva 5 Abnormal gait 6 spastic Hemeplegia 7 spastic Diplegia 8 spastic Quadriplegia 9 spastic Monoplegia 10 spastic Triplegia

Exclusion criteria

Exclusion criteria: 1 Ataxic cp 2 Flaccidity 3 Associated with Seziure disorder 4 Associated with Autism(ASD) 5 Associated with ADHD 6 Any other serious illness.

Design outcomes

Primary

Measure	Time frame
The modified Ashworth scale Gross Motor Function Classification System (GMFCS), Dynamic Gait Index.Timepoint: Pre studuy screening and after treatment	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the following parameters before and after treatment. Timepoint: Pre study screening and after treatment	—

Countries

India

Contacts

Public ContactShalini boopathi

National institute of siddha

drarulmozhi@yahoo.co.in9500151930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026